Charles Majoie is Professor of neuroradiology and interventional neuroradiologist in the Amsterdam UMC, location AMC, Amsterdam, The Netherlands. He is as a research leader and co-research leader involved in multiple national and international research collaborations in the field diagnosis and treatment of acute stroke. He was 1 of the 2 research leaders of the ground breaking MRCLEAN trial, that demonstrated a clear improvement in clinical outcome of patients with acute ischemic stroke after endovascular treatment. This changed the practice how patients with severe strokes are now treated worldwide. He is co research leader of the ongoing CONTRAST (MRCLEAN-2) trials aiming at treating more patients even more effectively and member of the executive committee of the HERMES Consortium: international collaboration of PIs of 7 randomized clinical trials in the field of endovascular treatment He is founder of the Neurovascular Intervention Center Amsterdam, a multidisciplinary center of excellence, combining patient care, research and education in the field of neurovascular diseases. He is  Principal Investigator of the AMC Research Institute and has supervised 25 PhD students and currently supervises another 14. He is Chairman of the Dutch Society of Neuroradiology.

He currently (Oct. 2018) has (co)authored more than 330 peer-reviewed manuscripts and has a Hirsch index of 42 (Web of Science).